The motivation and process for developing a consortium-wide time and motion study to estimate resource implications of innovations in the use of genome sequencing to inform patient care.

Autor: Hoban HG; Institute for Human Genetics, University of California, San Francisco, California, USA., Yip TA; Institute for Human Genetics, University of California, San Francisco, California, USA., Chau JC; Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Bensen JT; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Desrosiers LR; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Finnila CR; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA., Hindorff LA; Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Kelly NR; Division of Pediatric Genetic Medicine, Department of Pediatrics, Children's Hospital at Montefiore and the Albert Einstein College of Medicine, Bronx, New York, USA., Lynch FL; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA., Rolf BA; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA., Smith HS; Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, USA., Wasserstein MP; Division of Pediatric Genetic Medicine, Department of Pediatrics, Children's Hospital at Montefiore and the Albert Einstein College of Medicine, Bronx, New York, USA., Hassmiller Lich K; Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2024 Jan; Vol. 17 (1), pp. e13635. Date of Electronic Publication: 2023 Dec 08.